Results 191 to 200 of about 235,597 (396)

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

open access: yesInternational Journal of Cancer, EarlyView.
Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar   +2 more
wiley   +1 more source

Structural Studies of a Heavy Chain from a Mouse Immunoglobulin M with Antibody Activity

open access: hybrid, 1973
Elizabeth A. Robinson   +2 more
openalex   +1 more source

Integrated scFv identification and CAR T cell generation for AML targeting in vivo

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Acute myeloid leukemia (AML) is a rapidly progressing blood cancer. Advancing chimeric antigen receptor (CAR) T cell therapies, particularly through rapid translation of single chain variable fragment (scFv) discovery into CAR constructs, may improve clinical outcomes, especially the development of patient individualized CAR T cells.
Yi Liu   +13 more
wiley   +1 more source

Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.

open access: yesClinical Chemistry, 2015
J. Katzmann   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy